The enduring hope of a possible Covid-19 vaccine breakthrough is the kind of story where the ripple effect of such news will outlast any momentary splash it has.
Last week, pharmaceutical giant Pfizer and German research partner BioNTech did exactly that, announcing early test results of their
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
